ストックスクリーナーアプリを入手
319.43
0.31%
-0.99
アフターアワーズ：
320.00
0.57
+0.18%
前日終値:
$320.42
開ける：
$317.97
24時間の取引高:
316.47K
Relative Volume:
0.99
時価総額：
$6.40B
収益：
$274.48M
当期純損益:
$153.56M
株価収益率:
43.31
EPS:
7.3755
ネットキャッシュフロー:
$114.06M
1週間 パフォーマンス:
+1.06%
1か月 パフォーマンス:
+34.78%
6か月 パフォーマンス:
+59.75%
1年 パフォーマンス:
+180.79%
1日の値動き範囲:
$312.74
$323.30
1週間の範囲:
$305.31
$323.30
52週間の値動き範囲:
$114.00
$323.30
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
名前
Ligand Pharmaceuticals Inc
セクター
電話
858-550-7500
住所
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Compare LGND vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
319.43 | 6.42B | 274.48M | 153.56M | 114.06M | 7.3755 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.94 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.59 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-11 | 開始されました | BofA Securities | Buy |
| 2025-12-09 | 開始されました | Citigroup | Buy |
| 2025-04-10 | 開始されました | Stifel | Buy |
| 2024-10-03 | 開始されました | Oppenheimer | Outperform |
| 2024-07-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-04-14 | 再開されました | Stephens | Overweight |
| 2021-02-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-06 | 開始されました | Barclays | Overweight |
| 2020-03-24 | ダウングレード | Argus | Buy → Hold |
| 2020-03-10 | 開始されました | Guggenheim | Neutral |
| 2020-02-06 | 開始されました | The Benchmark Company | Buy |
| 2019-09-19 | アップグレード | Barclays | Equal Weight → Overweight |
| 2019-06-11 | 開始されました | Barclays | Equal Weight |
| 2019-05-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-03-06 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-10-29 | アップグレード | ROTH Capital | Neutral → Buy |
| 2018-10-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-09-11 | 繰り返されました | Argus | Buy |
| 2018-08-17 | 開始されました | Goldman | Neutral |
| 2018-08-08 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2018-06-21 | 開始されました | Argus | Buy |
| 2017-12-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-09-05 | 再開されました | H.C. Wainwright | Buy |
| 2016-10-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-05 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2016-03-11 | 開始されました | Sidoti | Buy |
| 2016-03-03 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Ligand Pharmaceuticals Inc (LGND) 最新ニュース
Form 4 Ligand Pharmaceuticals Incorporated For: 6 July By Investing.com - Investing.com Canada
Ligand Pharmaceuticals CLO Andrew Reardon sells $1.56m in shares By Investing.com - Investing.com Canada
[Form 4] LIGAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
Ligand Pharmaceuticals (LGND) CFO adds 17 shares through stock purchase plan - Stock Titan
LGND CEO Todd Davis acquires stock through employee plan in Form 4 filing - Stock Titan
Ligand Pharmaceuticals stock hits all-time high at 321.33 USD - Investing.com
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Ligand Pharmaceuticals explores licensing-driven growth as investors assess its royalty model - AD HOC NEWS
Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million -- WSJ - Moomoo
Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Ligand Pharmaceuticals Incorporated Bonds — Corporate Bond Rates - TradingView
US53220KAJ7 Bond Analysis — Key Metrics - TradingView
US53220KAJ7 Bond Price and Chart — FWB:US53220KAJ7 - TradingView
TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits
LGND: 10,000-share Section 144 notice; prior 10b5-1 sales by Reardon (LGND) - Stock Titan
Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator - Seeking Alpha
Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView
Ligand Pharmaceuticals reaches new 52-week high as insiders trim holdings - AD HOC NEWS
Zerion Pharma completes royalty financing and equity investment transaction with Ligand to advance the Dispersome® technology - marketscreener.com
Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView
Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView
Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView
Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView
Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView
Price to book forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView
Price to earnings forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView
Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Value Benchmark - marketscreener.com
Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView
Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView
Price to earnings forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView
Price to earnings forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView
Price to book forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 3000 Value Benchmark - marketscreener.com
Price to sales forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView
Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
XOMA Royalty (XOMA) Stock Fair Value Falls After Ligand Agrees Cash Acquisition - Yahoo Finance
Ligand Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:LGND) - TradingView
Ligand completes $700m convertible notes offering By Investing.com - Investing.com Australia
LGND Forecast — Price Target — Prediction for 2027 - TradingView
Ligand Pharmaceuticals Inc (LGND) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ligand Pharmaceuticals Incorporated Actuals & Estimates (SWB:LGDN) - TradingView
Ligand completes $700m convertible notes offering - Investing.com UK
LGDN Forecast — Price Target — Prediction for 2027 - TradingView
Ligand Pharmaceuticals Incorporated Actuals & Estimates (BOATS:LGND) - TradingView
Ligand Pharmaceuticals Prices Upsized $625 Million Zero-Coupon Convertible Notes Offering to Boost Financial Flexibility and Offset Dilution 1 – Minichart - Minichart
Ligand Raises $700M Via 0% Convertible Notes, Adds Note Hedges and $524.34 Strike Warrants - TradingView
Ligand (Nasdaq: LGND) raises $700M in 0% convertible notes with hedges - Stock Titan
Ligand Pharmaceuticals stock hits all-time high at 289.0 USD By Investing.com - Investing.com Australia
Ligand Pharmaceuticals Inc (LGND) 財務データ
収益
当期純利益
現金流量
EPS
Ligand Pharmaceuticals Inc (LGND) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Reardon Andrew | CLO & Secretary |
Jul 01 '26 |
Sale |
313.28 |
5,000 |
1,566,377 |
41,514 |
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):